Lords Mark Industries Limited

AI
Lords Mark Industries Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Lords Mark Industries Limited

₹ 75.1 -5.00%
21 Oct - close price
Company website BSE: 501261
About

Lord’s Mark Industries Ltd is the listed successor to Kratos Energy & Infrastructure Ltd after the 1998-incorporated operating company, erstwhile Lord’s Mark Industries Pvt Ltd, was absorbed through an NCLT-approved IBC reverse merger. It operates in diagnostics/MedTech, renewable-energy and LED projects, and legacy paper products.[1]

Key Points

Transition:[1]

NCLT approved the pre-pack resolution
/reverse merger on 28th July 2025; the operating private company merged into
listed Kratos, which became Lords Mark
India and then Lord’s Mark Industries w.e.f.
10 October 2025.

Website BSE
  • Market Cap ₹ 3,204 Cr.
  • Current Price ₹ 75.1
  • High / Low ₹ 99.0 / 60.0
  • Stock P/E 37.7
  • Book Value ₹ 24.4
  • Dividend Yield 0.00 %
  • ROCE 13.4 %
  • ROE 11.3 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 176% CAGR over last 5 years

Cons

  • Stock is trading at 3.08 times its book value
  • Company has a low return on equity of 10.8% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 341 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Services Services Commercial Services & Supplies Consulting Services

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
0 0 0 0 0 0 0 0 0 9 150 442 280
0 0 0 0 0 0 1 0 0 12 127 383 234
Operating Profit -0 -0 -0 -0 -0 -0 -1 -0 -0 -3 24 59 46
OPM % -30% 16% 13% 16%
0 0 0 0 0 0 -6 0 0 1 5 3 5
Interest 0 0 0 0 0 0 0 0 0 0 5 2 5
Depreciation 0 0 0 0 0 0 0 0 0 0 5 4 2
Profit before tax -0 -0 -0 -0 -0 -0 -6 -0 -0 -2 19 56 44
Tax % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 27% 27% 27%
-0 -0 -0 -0 -0 -0 -6 -0 -0 -2 14 41 32
EPS in Rs -1.40 -3.10 -0.40 -4.70 -0.50 -2.20 -64.20 -0.40 -0.30 -24.20 0.33 0.97 0.75
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
4 5 4 3 6 6 2 1 0 0 0 602 882
4 5 4 3 5 6 1 1 0 0 1 518 756
Operating Profit 0 0 0 -0 1 -0 0 0 -0 -0 -1 84 126
OPM % 2.5% 4.2% 1.9% -3.3% 16% -9% 25% 0.0% -145% 14% 14%
0 -0 0 1 0 1 0 0 0 0 -6 4 13
Interest 0 0 0 0 0 0 0 0 0 0 0 9 12
Depreciation 0 0 0 0 0 0 0 0 0 0 0 7 11
Profit before tax 0 0 0 1 1 0 0 0 -0 -1 -7 72 117
Tax % 43% 200% 31% 20% 25% 225% 26% 29% 0% 0% 0% 27%
0 -0 0 1 1 -0 0 0 -0 -1 -7 53 85
EPS in Rs 0.50 -0.50 2.50 7.80 9.10 -0.50 3.50 0.40 -1.60 -9.50 -67.30 1.24 -22.15
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 62%
5 Years: 216%
3 Years: 1662%
TTM: %
Compounded Profit Growth
10 Years: 80%
5 Years: 176%
3 Years: 605%
TTM: 9133%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -89%
Return on Equity
10 Years: 10%
5 Years: 11%
3 Years: 11%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 1 1 1 1 1 1 1 1 1 1 1 427
Reserves 2 2 2 3 4 4 4 4 4 3 -3 564
0 0 0 2 2 0 0 0 1 1 6 274
3 4 2 0 0 0 0 0 0 1 2 41
Total Liabilities 7 8 6 6 8 5 6 5 6 6 5 1,306
0 0 0 0 0 0 0 0 0 0 0 402
CWIP 0 0 0 0 0 0 0 0 0 0 0 4
Investments 0 2 1 2 3 0 0 0 0 0 0 0
6 6 5 4 5 5 6 5 6 6 5 901
Total Assets 7 8 6 6 8 5 6 5 6 6 5 1,306

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 1 0 -2 1 -2 1 -0 -1 0 -4 -383
-0 -1 -0 -0 -1 3 -0 0 0 0 0 -413
-0 -0 -0 2 0 -2 -0 0 1 0 4 940
Net Cash Flow -0 0 0 -0 0 -0 0 -0 -0 0 -0 143
Free Cash Flow 0 1 0 -2 1 -2 1 -0 -1 0 -4 -714
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 60% 550% -300% 1,100% 77% 331% 98% 862% 0% 467% -436%

Ratios

Standalone / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 0 0 0 0 1 44 0 20 0 341
Inventory Days 0 0 0 0 0 93
Days Payable 4
Cash Conversion Cycle 0 0 0 0 1 44 0 20 0 431
Working Capital Days -76 -160 -178 -172 -111 108 333 958 8,130 316
ROCE % 2% 5% 6% 17% 16% -7% 9% 1% -3% -9% -22% 13%

Insights

In beta
Mar 2016 Aug 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2026
Average Collection Period
days

Log in to view insights

Please log in to see hidden values.

Login
Order Book
Rs. crore
Solar/LED Segment Revenue
Rs. crore
MedTech Segment Revenue
Rs. crore
Dialysis Centres Operational
number
Dialysis Machine Manufacturing Capacity
machines per month
Dialysis Machine Order Book
machines

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

9 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
49.01% 49.01% 49.01% 49.01% 49.01% 49.01% 49.01% 49.01% 49.01% 80.84% 79.84% 75.30%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.30%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.42% 0.39%
50.99% 50.99% 50.99% 50.99% 50.99% 50.99% 50.99% 50.99% 50.99% 19.13% 19.74% 23.00%
No. of Shareholders 7778828888898787883,2103,25714,288

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls